The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease
Authors:
- Vilmantas GiedraitisVGVilmantas Giedraitis
- Johan SundelöfJSJohan Sundelöf
- Michael C. IrizarryMIMichael C. Irizarry
- Nina GårevikNGNina Gårevik
- Bradley T. HymanBHBradley T. Hyman
- Lars-Olof WahlundLWLars-Olof Wahlund
- Martin IngelssonMIMartin Ingelsson
- Lars LannfeltLLLars Lannfelt
- 1 November 2007
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 427 (3) , 127-131
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Plasma Aβ Levels Do Not Reflect Brain Aβ LevelsJournal of Neuropathology & Experimental Neurology, 2007
- Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older AdultsArchives of Neurology, 2007
- Human Apolipoprotein E4 Alters the Amyloid-β 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic ModelJournal of Neuroscience, 2005
- Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairmentNeurology, 2004
- Cerebrospinal fluid protein biomarkers for Alzheimer’s diseaseNeuroRX, 2004
- Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein LevelsArchives of Neurology, 2003
- Plasma Levels of Aβ42 and Aβ40 in Alzheimer Patients during Treatment with the Acetylcholinesterase Inhibitor TacrineDementia and Geriatric Cognitive Disorders, 2002
- Plaque‐associated disruption of CSF and plasma amyloid‐β (Aβ) equilibrium in a mouse model of Alzheimer's diseaseJournal of Neurochemistry, 2002
- Human and Murine ApoE Markedly Alters Aβ Metabolism before and after Plaque Formation in a Mouse Model of Alzheimer's DiseaseNeurobiology of Disease, 2002
- The Clinical Dementia Rating scaleNeurology, 1996